Use of carfilzomib in second-line therapy and beyond for relapsed multiple myeloma
Divaya Bhutani, Jeffrey A Zonder Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA Abstract: The development of proteasome inhibitors has been a major advance in therapy of multiple myeloma, accounting, in part, for the significant increase in the s...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/3d0a108b5d134eb4907426eb0441eb80 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|